Papillary Craniopharyngioma, also known as papillary rathke's pouch tumor, is related to craniopharyngioma and adenoma, and has symptoms including visual disturbance An important gene associated with Papillary Craniopharyngioma is CTNNB1 (Catenin Beta 1), and among its related pathways/superpathways are Oncogenic MAPK signaling and Corticotropin-releasing hormone signaling pathway. The drugs Vemurafenib and Trametinib have been mentioned in the context of this disorder. Affiliated tissues include pituitary and pineal.